DAVID HELSEL: Open Payments
NPI 1669463840 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 40 payments from 12 companies in 2025. Trend: 2023 $436 · 2024 $707 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $181 |
| Otsuka America Pharmaceutical, Inc. | 8 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $122 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Lundbeck LLC | 3 | $56 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| Alkermes, Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: SPRAVATO, REXULTI, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, Jornay PM, LYBALVI, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
